Related Experiment Videos
Nonsurgical reperfusion in evolving myocardial infarction
Insights
Intracoronary thrombolysis effectively restored blood flow in most acute myocardial infarction patients, preserving heart muscle. Continuous anticoagulation is crucial to prevent reocclusion after this promising nonsurgical treatment.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Nonsurgical recanalization of occluded coronary arteries using thrombolytic agents has been employed since the late 1970s for evolving myocardial infarction.
- Intracoronary thrombolysis involves administering agents directly to the occlusion site.
Purpose of the Study:
- To review the fundamental principles of intracoronary thrombolysis.
- To describe the institutional methodology for this procedure.
- To present and analyze the clinical outcomes of intracoronary thrombolysis.
Main Methods:
- The study involved intracoronary administration of thrombolytic agents to patients with acute myocardial infarction.
- Reperfusion success was assessed, and reocclusion rates were monitored.
- Thallium-201 scintigraphy was used pre- and post-reperfusion to evaluate myocardial salvage.
- Regional wall motion and left ventricular ejection fraction were assessed.
Main Results:
- Successful reperfusion or termination of ischemia was achieved in 87.7% (71 of 81) of patients.
- Reocclusion occurred in four patients, linked to temporary anticoagulation failure, highlighting the need for uninterrupted anticoagulation (aPTT > 80 seconds).
- Thallium scintigraphy demonstrated myocardial salvage in successful cases, correlating with improved regional wall motion and ejection fraction.
Conclusions:
- Intracoronary thrombolysis is a safe and promising nonsurgical approach for acute myocardial infarction.
- Effective reperfusion leads to myocardial salvage and functional improvement.
- Further large-scale controlled studies are necessary to definitively establish its role in acute myocardial infarction management.
Abstract:
Nonsurgical recanalization of the occluded coronary artery has been performed in patients with evolving myocardial infarction since the late 1970s by intracoronary administration of thrombolytic agents at the ostium of the occluded artery or directly to the site of occlusion. The authors review the basic concepts underlying intracoronary thrombolysis, the method applied at their institution and the clinical results. Reperfusion of totally occluded arteries or termination of the ischemic state in subtotally occluded arteries was achieved in 71 (87.7%) of 81 patients. Reocclusion occurred in four patients, in three of these at a time when anticoagulation became temporarily ineffective, emphasizing the need for uninterrupted anticoagulation with a partial thromboplastin time longer than 80 seconds. Thallium scintigraphic studies before and after reperfusion showed a decrease in defect, indicating myocardial salvage, in the successful cases but not in failures or untreated control subjects. A decrease in thallium-201 defect was followed by improvement of regional wall motion and usually also left ventricular ejection fraction. Three of the patients with an unsuccessful result and one patient with a successful result died. Bypass surgery was performed electively in 18 patients because of multiple vessel involvement. Intracoronary thrombolysis appears to be a relatively safe and promising procedure. A large controlled study will be needed for definitive assessment of its role in the management of acute myocardial infarction.